Try it
Pharmacology · Endocrine drugs: elagolix
Sample itemA woman with endometriosis-related pelvic pain is given the oral GnRH antagonist elagolix. Unlike depot leuprolide, it causes no initial flare of symptoms. Why?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. It blocks pituitary GnRH receptors at once, so LH and FSH fall without an initial surge
Elagolix competitively blocks pituitary GnRH receptors, so gonadotropin and oestradiol suppression is rapid and dose-dependent, with no flare. GnRH agonists first stimulate the receptor and cause a surge before desensitisation. Hot flushes and loss of bone density follow the hypo-oestrogenic state.
Option by option
A. It blocks pituitary GnRH receptors at once, so LH and FSH fall without an initial surge (correct)
Correct. Direct receptor blockade lowers LH and FSH immediately, with no surge.
B. It acts as a progesterone receptor agonist
Progesterone receptor agonism is the action of progestins such as dienogest.
C. It desensitises pituitary receptors after a period of overstimulation
Desensitisation after initial stimulation is the mechanism of GnRH agonists like leuprolide.
D. It inhibits aromatase in endometrial tissue
Aromatase inhibition is the action of letrozole and anastrozole, not of elagolix.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?